Publication | Closed Access

Increase in the skeletal muscle mass to body fat mass ratio predicts the decline in transaminase in patients with nonalcoholic fatty liver disease

ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisBody CompositionHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseMetabolic DisorderLiver PhysiologyPhysiologySkeletal Muscle MassLiver DiseaseFatty Liver DiseaseMetabolismMedicineHealth Sciences